Renato Fuchs
Plus aucun poste en cours
Provenance du réseau au premier degré de Renato Fuchs
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA.
17
| Subsidiary | Medical Specialties | 17 |
Transkaryotic Therapies, Inc.
 Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA.
13
| Extinct | Miscellaneous Commercial Services | 13 |
Altus Pharmaceuticals, Inc.
 Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA.
4
| Extinct | Biotechnology | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Renato Fuchs via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| WINDTREE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
| ARQULE, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Biotechnology | Chief Executive Officer Chief Executive Officer | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Chief Operating Officer | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Cytovance Biologics, Inc.
 Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Biotechnology | President | |
Calistoga Pharmaceuticals, Inc.
 Calistoga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Calistoga Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The company was founded by Michael W. Gallatin, Roger Ulrich and Neil Giese in March 2006 and is headquartered in Tumwater, WA. | Pharmaceuticals: Major | Director/Board Member | |
| OCULAR THERAPEUTIX, INC. | Pharmaceuticals: Major | Director/Board Member | |
| DICERNA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Undergraduate Degree | |
Novazyme Pharmaceuticals, Inc.
 Novazyme Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Novazyme Pharmaceuticals, Inc. researches and develops methods for modifying recombinantly produced enzymes. It develops a series of novel protein engineering technologies that have been shown in pre-clinical studies to greatly enhance the targeting and uptake of replacement enzymes. Novazyme's technologies also have application for developing advanced monoclonal antibodies and gene therapies. The company is located in Oklahoma City, OK. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Amherst College | College/University | Undergraduate Degree Undergraduate Degree | |
| Andrews University | College/University | Undergraduate Degree | |
SV Health Investors LLC
 SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | Investment Managers | Private Equity Investor | |
| Fairleigh Dickinson University | College/University | Masters Business Admin Masters Business Admin | |
| The Johns Hopkins University | College/University | Graduate Degree Undergraduate Degree | |
| Long Island University | College/University | Undergraduate Degree | |
| Yale University | College/University | Undergraduate Degree Corporate Officer/Principal | |
Warburg Pincus & Company US LLC
 Warburg Pincus & Company US LLC Investment ManagersFinance Warburg Pincus & Company US LLC engages in the provision of investment services. The company is headquartered in New York, NY. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Graduate Degree | |
| Villanova University | College/University | Undergraduate Degree Undergraduate Degree | |
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Pharmaceuticals: Generic | Director/Board Member | |
Lucile Salter Packard Children's Hospital at Stanford
 Lucile Salter Packard Children's Hospital at Stanford Hospital/Nursing ManagementHealth Services Lucile Salter Packard Children''s Hospital at Stanford engages in the provision of hospital services. It focuses on the obstetric and pediatric areas: brain and behavior, cancer, heart, pregnancy and newborn, pulmonary, and transplant. Its practices and services include anesthesia, cancer and blood diseases, cardiology, cardiovascular intensive care, dialysis, labor and delivery, neonatology, perinatal diagnostic center, pharmacy services, pulmonary function laboratory, radiology, rehabilitation services, social services, speech and language, and before and after surgical care. The company was founded in 1991 and is headquartered in Palo Alto, CA. | Hospital/Nursing Management | Director/Board Member | |
PanOptica, Inc.
 PanOptica, Inc. Pharmaceuticals: MajorHealth Technology PanOptica, Inc. operates as a biopharmaceutical company that provides ophthalmology drugs for treatment of eye diseases. The company was founded by Paul G. Chaney and Martin B. Wax in March 2009 and is headquartered in Bernardsville, NJ. | Pharmaceuticals: Major | Director/Board Member | |
| INVIVO THERAPEUTICS HOLDINGS CORP. | Biotechnology | Director of Finance/CFO Chief Executive Officer Compliance Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree | |
Invisible Sentinel, Inc.
 Invisible Sentinel, Inc. BiotechnologyHealth Technology Invisible Sentinel, Inc. engages in food diagnostics. It offers food safety, wine, beer products such as veriflow for salmonella, listerria species and vinoBrett for breetanomyces bruxellensis, vinoPAL for pedicoccus and lactobacillus and veriflow custom solutions. The company was founded by Nicholas Siciliano and Benjamin Pascal in October 2006 and is headquartered in Philadelphia, PA. | Biotechnology | Director/Board Member | |
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Biotechnology | Director/Board Member | |
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Biotechnology | Chairman | |
Agent Capital LLC
 Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | Investment Managers | Private Equity Investor | |
| STEALTH BIOTHERAPEUTICS CORP | Biotechnology | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Aro Biotherapeutics Co.
 Aro Biotherapeutics Co. BiotechnologyHealth Technology Aro Biotherapeutics Co. operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics products. It specializes in oncology, drug discovery, drug development, licensing, drug delivery, sirna, immunology, bispecifics, protein conjugation, protein therapeutics and protein engineering services. The company was founded by Karyn O?Neil and Susan Dillon in 2018 and is headquartered in Philadelphia, PA. | Biotechnology | Director/Board Member | |
180 Life Corp.
 180 Life Corp. Pharmaceuticals: MajorHealth Technology 180 Life Sciences Corp. engages in manufacture of pharmaceutical products. The company is headquartered in New York. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Interius BioTherapeutics, Inc.
 Interius BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Interius BioTherapeutics, Inc. is a biopharmaceutical company that targets cancer. The company was founded by Saar Gill and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Founder | |
Enosi Life Sciences Corp.
 Enosi Life Sciences Corp. BiotechnologyHealth Technology Enosi Life Sciences Corp. is a drug research and development company that focuses on providing therapeutics for autoimmune diseases and cancer. The private company is based in San Diego, CA, and was founded in 2018 by H. Michael Shepard and Marc Feldmann. Enosi Life Sciences combines their expertise with Dr. James N. Woody's medical, scientific, and management expertise to expand therapeutic options. The company was founded by Professor Sir Marc Feldmann and Dr. H. Michael Shepard, who are world-renowned scientists in the field of cancer and autoimmune diseases. Patrick W. Gray has been the CEO of the company since 2021. | Biotechnology | Chairman | |
| 180 LIFE SCIENCES CORP. | Pharmaceuticals: Major | Founder Chief Executive Officer | |
ViTToria Biotherapeutics, Inc.
 ViTToria Biotherapeutics, Inc. BiotechnologyHealth Technology viTToria Biotherapeutics, Inc. is a gene-edited cell therapeutics company based in Philadelphia, PA. The company is developing novel CAR-T cell therapies using their proprietary Senza5 platform, which maximizes stemness, durability, and target cell cytotoxicity. The technology is exclusively licensed from the University of Pennsylvania and has pipeline applications in oncology and autoimmune diseases. The company was founded by Bruce A. Peacock and Nicholas Siciliano, with Nicholas Siciliano serving as CEO since incorporation. | Biotechnology | Founder |
Statistiques
Internationale
| Etats-Unis | 50 |
| Royaume-Uni | 2 |
Sectorielle
| Health Technology | 34 |
| Consumer Services | 11 |
| Finance | 5 |
| Commercial Services | 3 |
| Health Services | 2 |
Opérationnelle
| Director/Board Member | 198 |
| Corporate Officer/Principal | 99 |
| Director of Finance/CFO | 60 |
| Independent Dir/Board Member | 54 |
| Undergraduate Degree | 32 |
Relations les plus connectées
| Insiders | |
|---|---|
| Daniel Geffken | 53 |
| Jonathan Leff | 45 |
| Jim Woody | 31 |
| Bruce Peacock | 28 |
| Lawrence Steinman | 26 |
| James Edward Thomas | 26 |
| Bobba Venkatadri | 24 |
| Roger J. Guidi | 20 |
| Tamara Joseph | 19 |
| Michael Dougherty | 18 |
| Gregory Perry | 16 |
| Bruce A. Leicher | 16 |
| Margaret Dalesandro | 13 |
| Shawn M. Marcell | 13 |
| Adi Mohanty | 12 |
- Bourse
- Insiders
- Renato Fuchs
- Connexions Sociétés
